Edition:
India

People: ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

31.61USD
1:30am IST
Change (% chg)

$0.22 (+0.70%)
Prev Close
$31.39
Open
$31.99
Day's High
$31.99
Day's Low
$30.80
Volume
40,097
Avg. Vol
37,663
52-wk High
$86.67
52-wk Low
$29.38

Schrepfer, Robert 

Mr. Robert W. Schrepfer serves as Senior Vice President - New Business Development and Specialty Sales of the Company. Prior to that, Mr. Schrepfer served as the Company’s Vice President of New Business Development and Contract Manufacturing since August 2013. From 2005 to 2013, Mr. Schrepfer served as Assistant Portfolio Manager at Healthcare Value Capital, LLC, an SEC-registered healthcare investment firm. Mr. Schrepfer co-managed the firm’s private equity portfolio and oversaw investments in healthcare services, devices and specialty pharmaceuticals. Between 2003 and 2005, Mr. Schrepfer was Managing Director at Bear Stearns & Co. Inc., providing sell side research coverage of the pharmaceuticals industry. Mr. Schrepfer served as Clinical Director and Director of Outcomes and Research at the Centers for Aquatic Rehabilitation from 1997 to 2001. Mr. Schrepfer received an M.B.A. in Finance and Health Sector Management from Duke University, an M.S. in Physical Therapy from the University of Indianapolis, and a B.A. degree from the University of Kansas. He is currently a member of the Alumni Council for the Fuqua School of Business at Duke University.

Basic Compensation

Total Annual Compensation, USD 708,997
Restricted Stock Award, USD 826,622
Long-Term Incentive Plans, USD --
All Other, USD 625,356
Fiscal Year Total, USD 2,160,980

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 11,796 760,168.00
Name Fiscal Year Total

Robert Brown

403,654

Patrick Walsh

303,334

Stephen Carey

2,156,390

Robert Schrepfer

2,160,980

James Marken

1,398,770

Thomas Haughey

315,278
As Of  31 Dec 2019